Recombinant Human Erythropoietin (rHuEPO) Injection

Vaccine Overview

This biologic is a synthetic form of the human hormone erythropoietin, crucial for red blood cell production. It's used to manage anemia due to chronic renal failure, cancer therapy, or other conditions affecting erythropoiesis. The injection helps restore normal hemoglobin levels and reduces the need for blood transfusions. It is administered under medical supervision, either intravenously or subcutaneously, with dosage adjusted based on patient response, hemoglobin levels, and overall treatment goals.

Drug Class: Recombinant and other Products

Indication: Used for the treatment of anemia, particularly in chronic renal failure, chemotherapy-induced anemia, and anemia from certain medical conditions like HIV/AIDS

PREVENTS

Anemia (various causes)

Vaccine Details

Applied To

Infants, Children, Adolescents, Adults

Recommended Time

As prescribed during clinical need

Administration

Route: Subcutaneous (SC) or Intravenous (IV)

Site: Upper arm, abdomen, or thigh (SC); vein (IV)

Disease

Anemia (various causes)

Manufacturer

Serum Intitute Of India

Age

All age groups

Disclaimer

This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.

Last updated: May 2, 2025